Loading data
HYMCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 0 USD | 33.23 m USD | 110.73 m USD |
| Cost of revenue | — | — | 0 USD | 53.59 m USD | 163.34 m USD |
| Research and development expense | 14.86 m USD | 19.53 m USD | 20.64 m USD | 18.36 m USD | 13.59 m USD |
| Operating profit | -44.47 m USD | -43.82 m USD | -45.01 m USD | -53.49 m USD | -83.91 m USD |
| Profit before tax | — | -60.9 m USD | -55.03 m USD | -60.83 m USD | -90.09 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | -1.53 m USD |
| Net income (reported basis) | -40.66 m USD | -60.9 m USD | -55.02 m USD | -60.83 m USD | -88.56 m USD |
| Basic earnings per share | -0.94 USD/share | -2.63 USD/share | -2.61 USD/share | -3.58 USD/share | -1.47 USD/share |
| Diluted earnings per share | -0.94 USD/share | -2.63 USD/share | -2.61 USD/share | -3.58 USD/share | -1.47 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.